Update regarding pfizer's statement on comirnaty-related write-offs

Mainz, germany, october 16, 2023 (globe newswire) -- on october 13, 2023, pfizer inc. (nyse: pfe, “pfizer”), a collaboration partner of biontech se (nasdaq: bntx, “biontech” or “the company”), announced a non-cash charge for inventory write-offs and other charges related to comirnaty of $0.9 billion. the company has been informed by pfizer that the majority of the write-offs relate to raw materials, mainly formulation-related lipids, purchased during the pandemic, as well as covid-19 vaccine doses adapted to other, non-xbb.1.5 variants produced at risk. according to pfizer, the write-offs do not address pfizer-biontech covid-19 vaccine doses adapted to the xbb.1.5 variant, which has been approved and is being marketed in key geographies.
BNTX Ratings Summary
BNTX Quant Ranking